COVID-19: Vaccines and Therapeutics
A summary of important information for providers on Johnson & Johnson’s COVID-19 vaccine.
The House of Representatives early this morning voted 219-212 to approve a modified version of the American Rescue Plan Act of 2021, legislation to provide reconciliation protection for a roughly $1.9 trillion COVID-19 relief package, which includes a number of provisions that affect hospitals and…
- Novel Coronavirus (SARS-CoV-2/COVID-19)
- Legislation and Legislative Advocacy
- Advocacy & Public Policy
- COVID-19: Vaccines and Therapeutics
- Medicaid
- Marketplace Issues/Stability
- Medicare DSH
- Substance Use Disorder
- Behavioral Health Intervention & Issues Prevention
- Workforce
- Skilled Nursing Facility PPS
- OSHA
- Rural issues
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee recommended the approval of Johnson & Johnson’s COVID-19 vaccine candidate.
Israeli patients aged 70 and older were much less likely to require mechanical ventilation for COVID-19 after most people in their age group had received the second dose of the Pfizer vaccine, according to a study released by the Centers for Disease Control and Prevention.
AHA released a one-stop web hub for hospitals and health systems to find communication resources related to COVID-19 vaccines.
The Food and Drug Administration will allow undiluted frozen vials of the Pfizer COVID-19 vaccine to be transported and stored at conventional pharmaceutical freezer temperatures (-13°F to 5°F) for up to two weeks as an alternative to its preferred storage at -112 F to -76ºF, the agency announced…
The Food and Drug Administration's Office of Minority Health and Health Equity released two videos on COVID-19 vaccines and the importance of communities of color who have been disproportionately impacted by COVID-19 getting vaccinated to protect themselves and loved ones from the virus.
The AHA has received $6 million in grants from the Centers for Disease Control and Prevention to promote clinician and public confidence in COVID-19 vaccines, and help train current and future health care personnel to prevent and control infectious disease.
Data submitted to the Food and Drug Administration confirms that Johnson & Johnson’s COVID-19 vaccine candidate is safe and effective.
The Department of Veterans Affairs’ Community Care Network now offers COVID-19 vaccinations to eligible veterans nationwide at its urgent care and retail pharmacy locations, the agency reports.